Valuation: ChemoMetec A/S

Capitalization 7B 1.11B 937M 856M 819M 1.51B 100B 1.57B 9.98B 3.95B 48.45B 4.16B 4.07B 170B P/E ratio 2026 *
30.9x
P/E ratio 2027 * 25x
Enterprise value 6.61B 1.05B 885M 808M 773M 1.43B 94.83B 1.48B 9.42B 3.73B 45.74B 3.92B 3.84B 161B EV / Sales 2026 *
11.7x
EV / Sales 2027 * 9.63x
Free-Float
96.32%
Yield 2026 *
1.71%
Yield 2027 * 1.83%
1 day+0.35%
1 week-2.62%
Current month-34.01%
1 month-43.51%
3 months-46.73%
6 months-19.72%
Current year-41.50%
1 week 392.4
Extreme 392.4
415
1 month 392.4
Extreme 392.4
707
Current year 392.4
Extreme 392.4
732.5
1 year 367
Extreme 367
804
3 years 255
Extreme 255
804
5 years 255
Extreme 255
1,149
10 years 25.4
Extreme 25.4
1,149
Manager TitleAgeSince
Chief Executive Officer 33 2024-03-12
Chief Tech/Sci/R&D Officer - 2023-12-19
Chief Tech/Sci/R&D Officer - 2010-11-30
Director TitleAgeSince
Director/Board Member 67 2013-09-30
Director/Board Member 64 2014-09-30
Director/Board Member 50 -
Change 5d. change 1-year change 3-years change Capi.($)
+0.35%-2.62%-30.89%-21.67% 1.11B
+0.51%+0.61%+26.93%+28.84% 13.29B
+34.22%+30.27%-3.65%+6.03% 6.99B
+0.78%-3.49%-6.17%-14.91% 6.02B
-1.81%-3.73%+2.29%+26.25% 5.48B
-2.37%+10.48%+5.90%+23.05% 5B
-1.79%-3.64%-8.08%+44.37% 4.74B
-1.64%-3.39%+7.54%-57.37% 1.66B
+0.76%+0.76%+14.02%+20.08% 1.46B
-0.51%+11.65%+9.62%-10.63% 1.36B
Average +2.85%+1.16%+1.75%+4.40% 4.71B
Weighted average by Cap. +4.64%+0.20%+6.60%+14.88%

Financials

2026 *2027 *
Net sales 562M 89.04M 75.28M 68.75M 65.82M 122M 8.07B 126M 802M 318M 3.89B 334M 327M 13.68B 675M 107M 90.42M 82.57M 79.05M 146M 9.69B 151M 963M 381M 4.68B 401M 393M 16.43B
Net income 226M 35.81M 30.27M 27.65M 26.47M 48.9M 3.25B 50.69M 323M 128M 1.57B 134M 132M 5.5B 292M 46.17M 39.04M 35.65M 34.13M 63.06M 4.19B 65.37M 416M 165M 2.02B 173M 170M 7.09B
Net Debt -391M -61.96M -52.38M -47.84M -45.8M -84.61M -5.62B -87.71M -558M -221M -2.71B -232M -228M -9.52B -493M -78.11M -66.04M -60.31M -57.74M -107M -7.08B -111M -704M -279M -3.42B -293M -287M -12B
Logo ChemoMetec A/S
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Employees
172
Date Price Change Volume
26-02-17 402.20 kr +0.35% 55,753
26-02-16 400.80 kr -0.64% 58,303
26-02-13 403.40 kr -0.84% 49,946
26-02-12 406.80 kr +2.99% 80,783
26-02-11 395.00 kr -4.36% 131,986
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
402.20DKK
Average target price
771.25DKK
Spread / Average Target
+91.76%

Quarterly revenue - Rate of surprise